Eupraxia Pharmaceuticals EPRXF Stock
Eupraxia Pharmaceuticals Price Chart
Eupraxia Pharmaceuticals EPRXF Financial and Trading Overview
| Eupraxia Pharmaceuticals stock price | 3.04 USD |
| Previous Close | 5.5 USD |
| Open | 5.5 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 5.5 - 5.5 USD |
| 52 Week Range | 0.85 - 6 USD |
| Volume | 130 USD |
| Avg. Volume | 481 USD |
| Market Cap | 122.61M USD |
| Beta (5Y Monthly) | 1.170873 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EPRXF Valuation Measures
| Enterprise Value | 110.13M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 13.853904 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.505 |
Trading Information
Eupraxia Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.170873 |
| 52-Week Change | 378.26% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6 USD |
| 52 Week Low | 0.85 USD |
| 50-Day Moving Average | 4.53 USD |
| 200-Day Moving Average | 2.97 USD |
EPRXF Share Statistics
| Avg. Volume (3 month) | 481 USD |
| Avg. Daily Volume (10-Days) | 163 USD |
| Shares Outstanding | 21.77M |
| Float | 13.24M |
| Short Ratio | N/A |
| % Held by Insiders | 12.22% |
| % Held by Institutions | 20.15% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -65.31% |
| Return on Equity (ttm) | -215.58% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -24445916 USD |
| Net Income Avi to Common (ttm) | -24528468 USD |
| Diluted EPS (ttm) | -0.88 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.85M USD |
| Total Cash Per Share (mrq) | 0.87 USD |
| Total Debt (mrq) | 10.82M USD |
| Total Debt/Equity (mrq) | 153.27 USD |
| Current Ratio (mrq) | 8.82 |
| Book Value Per Share (mrq) | 0.397 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21056280 USD |
| Levered Free Cash Flow (ttm) | -13397814 USD |
Profile of Eupraxia Pharmaceuticals
| Country | United States |
| State | BC |
| City | Victoria |
| Address | 2067 Cadboro Bay Road |
| ZIP | V8R 5G4 |
| Phone | 250-590-3968 |
| Website | https://www.eupraxiapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 21 |
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. In addition, the company develops product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Q&A For Eupraxia Pharmaceuticals Stock
What is a current EPRXF stock price?
Eupraxia Pharmaceuticals EPRXF stock price today per share is 3.04 USD.
How to purchase Eupraxia Pharmaceuticals stock?
You can buy EPRXF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eupraxia Pharmaceuticals?
The stock symbol or ticker of Eupraxia Pharmaceuticals is EPRXF.
Which industry does the Eupraxia Pharmaceuticals company belong to?
The Eupraxia Pharmaceuticals industry is Biotechnology.
How many shares does Eupraxia Pharmaceuticals have in circulation?
The max supply of Eupraxia Pharmaceuticals shares is 35.62M.
What is Eupraxia Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Eupraxia Pharmaceuticals PE Ratio is 0.00000000 now.
What was Eupraxia Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Eupraxia Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Eupraxia Pharmaceuticals company belong to?
The Eupraxia Pharmaceuticals sector is Healthcare.